Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
about
Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorderAntidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorderSubanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effectMidline and right frontal brain function as a physiologic biomarker of remission in major depressionTelemonitoring with respect to mood disorders and information and communication technologies: overview and presentation of the PSYCHE projectRostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depressionThe effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data.Biomarkers to predict antidepressant responseRostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.Cortical functional activity in patients with generalized anxiety disorderUse of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence.The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.Electroencephalogram-based pharmacodynamic measures: a review.Electrocortical features of depression and their clinical utility in assessing antidepressant treatment outcome.EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response.Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.Changes in brain function during administration of venlafaxine or placebo to normal subjects.Neural Network Based Response Prediction of rTMS in Major Depressive Disorder Using QEEG CordanceAnalysis of Brain Functional Changes in High-Frequency Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression.Treatment results of anorexia nervosa and bulimia nervosa in a residential treatment program.Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.Alpha Wavelet Power as a Biomarker of Antidepressant Treatment Response in Bipolar Depression.QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'.QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response
P2860
Q26823991-3A60DECA-5D7F-4FF3-B7C5-DD53EA58B535Q28252973-11CF320F-F914-4EC4-AF74-58BF9749B8E6Q28267032-84885608-BBC3-42D1-A033-EA2A5D0D542EQ29399995-DD381B71-56B9-4004-A56B-DE3E664D0F89Q30434498-542BFE06-6702-4FCC-8E73-853FFBB42D21Q30488794-7FD0ADCB-89EE-474A-8DEB-C943C294A175Q30825123-5C96D139-339E-4C00-9A1F-DB8E03825569Q34247513-A1BF9C56-E31A-4109-A1B7-E6DADDE91236Q35153746-7846D9E3-69CE-408E-99DA-57BBAF2981A6Q35237042-4E9C6C7F-8857-4C22-B3F9-26B1515006E6Q35547596-315853D1-2A61-442A-A8C6-DDAFA4FB1B18Q36070148-C371A1B4-1CC9-45FE-9C47-BF9156E8CFADQ37522358-B6BA8B70-28F1-47F3-B038-8A601D43B6AEQ37812199-5EC35A7F-A741-4C05-9048-7FC6F49D4E1AQ37989009-2107F26F-F330-49AC-A80F-35B914E93B3FQ38149983-1152242C-50C2-4562-8A95-AC307E031CD4Q38154919-B8EBA040-7276-4216-8156-E75088933C0BQ38864824-7D4F4FA3-70F9-4DC1-9FD5-D8ED682BC0C5Q39122800-45295042-B482-43E2-9941-210F7CE24B65Q40023174-1F789659-FF77-48FC-8543-104FD1370BC2Q41451392-5AA1487C-1FCD-4667-A997-7FFE6C97CD23Q44970723-22C43B42-2AEA-46CA-BCE2-701B1A23487DQ45815797-E0BBB18C-BCA3-4D44-BD6F-242F9779E9E1Q47666907-005D5DED-039E-43F4-8A6A-407FCC2BBF6FQ47910495-95DA059F-F898-41FA-A1C5-8ACD5AAE8CE4Q48317822-482EFE59-74FD-468B-8375-7A953EAAE0FCQ48642530-D7A958B4-2FA9-4135-ADE7-8E90C5BE5267Q58721391-97D9DABF-8368-4312-9486-C512DA433D5C
P2860
Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Changes in QEEG prefrontal cor ...... ssive disorder: a pilot study.
@en
Changes in QEEG prefrontal cor ...... ssive disorder: a pilot study.
@nl
type
label
Changes in QEEG prefrontal cor ...... ssive disorder: a pilot study.
@en
Changes in QEEG prefrontal cor ...... ssive disorder: a pilot study.
@nl
prefLabel
Changes in QEEG prefrontal cor ...... ssive disorder: a pilot study.
@en
Changes in QEEG prefrontal cor ...... ssive disorder: a pilot study.
@nl
P2093
P50
P1476
Changes in QEEG prefrontal cor ...... ssive disorder: a pilot study.
@en
P2093
Cyril Höschl
Jiri Kozeny
Pavla Stopkova
P304
P356
10.1016/J.JPSYCHIRES.2006.06.005
P577
2006-08-04T00:00:00Z